TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36161796

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tie-over bolster dressing
Number of subjects: 86
Study: 34126053

Group type: EXPERIMENTAL
Intervention: Discontinuation of RAS inhibition
Number of subjects: 204

Group type: COMPARATOR
Intervention: Continuation of RAS inhibition
Number of subjects: 204
Study: 32568108

Group type: EXPERIMENTAL
Intervention: CD‐LD ER
Number of subjects: 393

Group type: COMPARATOR
Intervention: CD‐LD IR
Number of subjects: 393
Study: 35476128

Group type: EXPERIMENTAL
Intervention: Volar-locking plate (VLP) fixation
Number of subjects: 166

Group type: COMPARATOR
Intervention: Closed reduction (CR)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: VLP fixation
Number of subjects: 166

Group type: COMPARATOR
Intervention: CR
Number of subjects: 166
Study: 32985580

Group type: EXPERIMENTAL
Intervention: Complete intraureteral stent placement (CIU-SP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional stent placement (C-SP)
Number of subjects: 80
Study: 35389239

Group type: EXPERIMENTAL
Intervention: Perioperative behavioral program (education, pelvic floor muscle training, progressive exercises, bladder control techniques) delivered by mHealth for 1-4 weeks preoperatively and 8 weeks postoperatively
Number of subjects: 245

Group type: COMPARATOR
Intervention: General prostate cancer education control condition delivered by mHealth for 1-4 weeks preoperatively and 8 weeks postoperatively
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Perioperative behavioral program
Number of subjects: 245

Group type: COMPARATOR
Intervention: General prostate cancer education control condition
Number of subjects: 245
Study: 34810364

Group type: EXPERIMENTAL
Intervention: Early implant placement at 8 weeks with A-PRF
Number of subjects: 20

Group type: COMPARATOR
Intervention: Early implant placement at 6 weeks with A-PRF
Number of subjects: 20
Study: 35304019

Group type: EXPERIMENTAL
Intervention: Ginger capsules (250 mg, four capsules)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsules (four capsules)
Number of subjects: 60
Study: 34581193

Group type: EXPERIMENTAL
Intervention: Elderly-choice group (freedom of choice)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Staff choice group (no freedom of choice)
Number of subjects: 157
Study: 33327586

Group type: EXPERIMENTAL
Intervention: High-volume moderate-intensity continuous training
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: High-volume high-intensity interval training (HIIT)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Low-volume HIIT
Number of subjects: 253

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 253
Study: 36267503

Group type: EXPERIMENTAL
Intervention: Implantable Loop Recorder (ILR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional extended Holter monitoring
Number of subjects: 30
Study: 32236602

Group type: EXPERIMENTAL
Intervention: Hispidulin
Number of subjects: 2

Group type: COMPARATOR
Intervention: Glutathione (ROS inhibitor)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Tauroursodeoxycholic acid (ER stress inhibitor)
Number of subjects: 2
Study: 32530373

Group type: EXPERIMENTAL
Intervention: Acupressure with ice
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acupressure without ice
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 35647367

Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including perceived disease susceptibility
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including self-efficacy to enact preventative behaviors
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including education
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including non-smoking status
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including marital status
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Health Beliefs Model constructs including perceived barriers to disease preventative behaviors
Number of subjects: 486
Study: 32088602

Group type: EXPERIMENTAL
Intervention: Play for Success intervention with Teach Two (simple structured direction)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Play for Success intervention with Teach Many (more complex structured direction)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Play for Success intervention with Social (unstructured direction)
Number of subjects: 42
Study: 35703608

Group type: EXPERIMENTAL
Intervention: 20-hour training on suicidal behavior
Number of subjects: 261

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 261
Study: 33634831

Group type: EXPERIMENTAL
Intervention: Real-transcranial direct current stimulation combined with cognitive training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham-transcranial direct current stimulation combined with cognitive training
Number of subjects: 50
Study: 34849536

Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation (28,000 IU/wk)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation (28,000/28,000 IU/wk)
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1300
Study: 33872104

Group type: EXPERIMENTAL
Intervention: Low-fidelity simulation training
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation training
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Lecture with procedural skills lab
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (existing online course)
Number of subjects: 147
Study: 32359376

Group type: EXPERIMENTAL
Intervention: BFR1 (one session of BFR training)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: BFR2 (two sessions of BFR training)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: WBFR1 (one session of resistance training without BFR)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: WBFR2 (two sessions of resistance training without BFR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (without training)
Number of subjects: 40
Study: 33174464

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 47

Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 47

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 47
Study: 34341554

Group type: EXPERIMENTAL
Intervention: Reappraisal interventions (reconstrual or repurposing)
Number of subjects: 21644

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 21644

Group type: COMPARATOR
Intervention: Passive control condition
Number of subjects: 21644
Study: 34991343

Group type: EXPERIMENTAL
Intervention: Behavioral Health Social Workers (BHSWs) deployed in primary care practices after diagnosis.
Number of subjects: 68659
Study: 32898681

Group type: EXPERIMENTAL
Intervention: MV‐IWAS
Number of subjects: 1578

Group type: COMPARATOR
Intervention: UV‐IWAS
Number of subjects: 1578
Study: 35206134

Group type: EXPERIMENTAL
Intervention: Cranial Electrotherapy Stimulation (CES) for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (sham CES) for 2 weeks
Number of subjects: 20
Study: 34324397

Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/d)
Number of subjects: 306
Study: 32334460

Group type: COMPARATOR
Intervention: Low dose prednisolone (5 mg daily for two months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High dose prednisolone (50 mg for three days, 25 mg for three days, 12.5 mg for three days, and 5 mg daily afterwards for two months)
Number of subjects: 30
Study: 34053343

Group type: EXPERIMENTAL
Intervention: Clenching at 50% MVC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clenching at moderate effort
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clenching at maximum effort
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clenching at >25% MVC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Clenching at increasing strength
Number of subjects: 20
Study: 33620746

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 128
Study: 32253263

Group type: COMPARATOR
Intervention: 0 IIS C-R/R autodialer messages
Number of subjects: 62118

Group type: EXPERIMENTAL
Intervention: 1 IIS C-R/R autodialer message
Number of subjects: 62118

Group type: EXPERIMENTAL
Intervention: 2 IIS C-R/R autodialer messages
Number of subjects: 62118

Group type: EXPERIMENTAL
Intervention: 3 IIS C-R/R autodialer messages
Number of subjects: 62118
Study: 34742607

Group type: EXPERIMENTAL
Intervention: Medication for opioid use disorder (MOUD)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 188
Study: 35135417

Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 0
Study: 33512942

Group type: EXPERIMENTAL
Intervention: Protocol-guided strategy utilizing stroke volume variation to guide administration of bolus fluid
Number of subjects: 715

Group type: COMPARATOR
Intervention: Usual care fluid administration
Number of subjects: 715
Study: 33160266

Group type: EXPERIMENTAL
Intervention: MMN measured using different ERP processing methods at electrode Fz.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Single-facet G-coefficients averaged across laboratories.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MMN amplitude reliability.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mastoid referencing for MMN measurement.
Number of subjects: 8
Study: 35460158

Group type: EXPERIMENTAL
Intervention: Intralesional tranexamic acid (TXA) 4 mg/ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Platelet rich plasma (PRP)
Number of subjects: 40
Study: 34428356

Group type: EXPERIMENTAL
Intervention: AR19 20 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: AR19 40 mg
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 33740215

Group type: EXPERIMENTAL
Intervention: HIV intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 0
Study: 32271144

Group type: EXPERIMENTAL
Intervention: Montelukast/levocetirizine fixed-dose combination (5/5 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Montelukast (5 mg) and levocetirizine (5 mg) administered separately
Number of subjects: 22
Study: 34272224

Group type: EXPERIMENTAL
Intervention: Phone survey on COVID-19-related attitudes, risk perceptions, preventive behaviours, and economic impact
Number of subjects: 600
Study: 32538082

Group type: EXPERIMENTAL
Intervention: Watermelon flesh (WF)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Watermelon rind (WR)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Watermelon seeds (WS)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 6
Study: 35357635

Group type: EXPERIMENTAL
Intervention: S-1 (equal-dosed)
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: S-1 (over-dosed)
Number of subjects: 938

Group type: COMPARATOR
Intervention: S-1 (under-dosed)
Number of subjects: 938
Study: 33780748

Group type: EXPERIMENTAL
Intervention: Secure attachment priming
Number of subjects: 101

Group type: COMPARATOR
Intervention: Oxytocin administration
Number of subjects: 101

Group type: COMPARATOR
Intervention: Combination of secure attachment priming and oxytocin
Number of subjects: 101
Study: 35443789

Group type: EXPERIMENTAL
Intervention: LRYGB
Number of subjects: 58

Group type: COMPARATOR
Intervention: DSE
Number of subjects: 58
Study: 35633633

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT) lung cancer screening; biennial screening preferred; PLCOm2012 risk calculation model with a threshold of 1.5% risk for developing cancer in the next six years.
Number of subjects: 0
Study: 34111952

Group type: EXPERIMENTAL
Intervention: ixazomib-Rd
Number of subjects: 722

Group type: COMPARATOR
Intervention: placebo-Rd
Number of subjects: 722
Study: 32927075

Group type: EXPERIMENTAL
Intervention: High-dose digestive enzyme treatment (Excelase: 3.0 g/day; Pancreatin: 3.0 g/day; Berizym: 3.0 g/day; Toughmac-E: 3.0 g/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal-dose digestive enzyme treatment (Excelase: 3.0 g/day)
Number of subjects: 80
Study: 36271304

Group type: EXPERIMENTAL
Intervention: Potentially inappropriate medications spending
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34535522

Group type: EXPERIMENTAL
Intervention: High ESR and normal CRP values
Number of subjects: 1472

Group type: EXPERIMENTAL
Intervention: High CRP and normal ESR values
Number of subjects: 1472
Study: 35101183

Group type: EXPERIMENTAL
Intervention: FeNO plus symptom-guided treatment
Number of subjects: 509

Group type: COMPARATOR
Intervention: Symptom-guided treatment alone (standard care)
Number of subjects: 509
Study: 34462242

Group type: EXPERIMENTAL
Intervention: Open-bite Bionator (OBB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Removable posterior bite plane with a tongue crib (RPBP/C)
Number of subjects: 40
Study: 34321123

Group type: EXPERIMENTAL
Intervention: 3D-printed endoport
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard open surgery (OS)
Number of subjects: 36
Study: 34607344

Group type: EXPERIMENTAL
Intervention: Regular blood transfusion
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 196
Study: 34562328

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (OSS)
Number of subjects: 199

Group type: COMPARATOR
Intervention: 2-L polyethylene glycol with ascorbic acid (PEG-Asc)
Number of subjects: 199
Study: 34556118

Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32771002

Group type: EXPERIMENTAL
Intervention: Multi-faceted implementation strategy including education about out-of-office testing, demonstration/instruction on HBPM and ABPM testing, feedback on completion rates, environmental prompts via CDS tool, and a culturally tailored ABPM testing service.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 63
Study: 35416502

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (5 times/week, 30 min each time for 3 months)
Number of subjects: 70
Study: 32959502

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 4107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4107
Study: 33508753

Group type: EXPERIMENTAL
Intervention: Vaccine intervention
Number of subjects: 413
Study: 32413284

Group type: EXPERIMENTAL
Intervention: Genetically predicted proteins derived from the dorsolateral prefrontal cortex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DCC gene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SARM1 gene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SNX32 gene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CTSH gene
Number of subjects: 0
Study: 36261812

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) treatment
Number of subjects: 6865
Study: 32657806

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Noisy PSV
Number of subjects: 24

Group type: COMPARATOR
Intervention: PCV
Number of subjects: 24
Study: 33284131

Group type: EXPERIMENTAL
Intervention: Mediterranean diet enriched with extra virgin olive oil (EVOO)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 720
Study: 35986421

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy based on rScO2 monitoring
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (conventional management)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 159
Study: 32668428

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (MEPD) tablets
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intravenous MEPD injection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intratympanic MEPD injection
Number of subjects: 90
Study: 32094396

Group type: EXPERIMENTAL
Intervention: Leptospirosis cohort
Number of subjects: 3393

Group type: COMPARATOR
Intervention: Non‐leptospirosis cohort (control)
Number of subjects: 3393

Group type: EXPERIMENTAL
Intervention: Leptospirosis cohort aged ≥65 years
Number of subjects: 3393
Study: 36469914

Group type: EXPERIMENTAL
Intervention: Dapagliflozin, 10 mg once daily
Number of subjects: 4304

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 4304
Study: 33174126

Group type: EXPERIMENTAL
Intervention: Various interventions to improve UTI diagnosis in nursing home residents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic time-out protocol
Number of subjects: 0
Study: 32498088

Group type: EXPERIMENTAL
Intervention: OAT (Horizon 201 oats/Prine annual ryegrass)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: TRIT (Trical 342 triticale/Prine annual ryegrass)
Number of subjects: 9

Group type: COMPARATOR
Intervention: RYE (FL401 cereal rye/Prine annual ryegrass)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: OAT
Number of subjects: 9

Group type: COMPARATOR
Intervention: RYE
Number of subjects: 9
Study: 35149167

Group type: COMPARATOR
Intervention: Surgical debridement
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Platelet-derived growth factor dressing
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Dehydrated amnion dressing
Number of subjects: 243
Study: 33622590

Group type: EXPERIMENTAL
Intervention: Multivalent vaccine containing nine serogroups (A, B, C, D, E, F, G, H, I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential bivalent vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly foot-bathing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivalent vaccines containing six serogroups (A, B, C, G, H, I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-month inter-vaccination interval for bivalent vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-month inter-vaccination interval for bivalent vaccines
Number of subjects: 0
Study: 32279529

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (Olmesartan), duration 1 year
Number of subjects: 0
Study: 35615840

Group type: EXPERIMENTAL
Intervention: Live modeling technique (mother as model)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Tell-Show-Do technique
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Live modeling technique (father as model)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Oxygen saturation
Number of subjects: 138
Study: 32599106

Group type: EXPERIMENTAL
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 18997

Group type: EXPERIMENTAL
Intervention: Carotid Stenting (CAS)
Number of subjects: 18997
Study: 35482647

Group type: EXPERIMENTAL
Intervention: Alcohol BMI plus behavioral economic substance-free activity session (BMI + SFAS)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Education
Number of subjects: 66
Study: 32769524

Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid (10%) with microneedling
Number of subjects: 40

Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 40
Study: 33953123

Group type: EXPERIMENTAL
Intervention: Methadone + disulfiram (250 mg/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Methadone + placebo
Number of subjects: 70
Study: 33039992

Group type: EXPERIMENTAL
Intervention: Ductal lavage and breast massage
Number of subjects: 140

Group type: COMPARATOR
Intervention: Oral corticosteroids (meprednisone or prednisone for 6 months)
Number of subjects: 140
Study: 35659776

Group type: EXPERIMENTAL
Intervention: Sleep-Extend intervention (6 weeks of using a Fitbit, weekly digital content, and weekly coaching)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (healthy living information)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sleep-Extend intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 32233959

Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 188

Group type: COMPARATOR
Intervention: MCV4-TT
Number of subjects: 188
Study: 35085152

Group type: EXPERIMENTAL
Intervention: Preemptive intervention
Number of subjects: 0
Study: 32949986

Group type: EXPERIMENTAL
Intervention: Early intervention arm of the IMPACT-AFib trial (98,903 patients)
Number of subjects: 197806

Group type: COMPARATOR
Intervention: Patients with evidence of OAC use in the prior 12 months
Number of subjects: 197806
Study: 35037278

Group type: EXPERIMENTAL
Intervention: High-dose topiramate (up to 250 mg/day)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low-dose topiramate (up to 125 mg/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 36306283

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous positive HPV test
Number of subjects: 18448

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous positive co-test
Number of subjects: 18448

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous negative HPV test
Number of subjects: 18448

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous negative co-test
Number of subjects: 18448

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous HPV16-positive test
Number of subjects: 18448

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous HPV16-negative/HPVother-positive test
Number of subjects: 18448

Group type: EXPERIMENTAL
Intervention: HPV-negative women with previous abnormal cytology
Number of subjects: 18448

Group type: COMPARATOR
Intervention: HPV-negative women
Number of subjects: 18448
Study: 32483059

Group type: EXPERIMENTAL
Intervention: Active exergames training (Wii Fit Plus) for 4 weeks, 2 sessions per week
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 72
Study: 33663418

Group type: EXPERIMENTAL
Intervention: Nutrition and reproductive health education (2 hours every 2 weeks for 3 months)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Regular health care services (control group)
Number of subjects: 194
Study: 34029555

Group type: EXPERIMENTAL
Intervention: High-energy ESWT (HS) group (energy flux density of 0.01 mJ/mm2, 5.8 bar, 1500 impulses, once per week for 4 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-energy ESWT (LS) group (energy flux density of 0.006 mJ/mm2, 3 bar, 1500 impulses, once per week for 4 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 60
Study: 32603212

Group type: EXPERIMENTAL
Intervention: iArmS robotic armrest
Number of subjects: 18

Group type: COMPARATOR
Intervention: No iArmS
Number of subjects: 18